NCT00452608UnknownPhase 2
Use of Statins in Modulation of Inflammatory Answer in Septic Patients
Hospital de Clinicas de Porto Alegre1 site in 1 country80 target enrollmentStarted: December 2006Last updated:
Conditions
Interventions
Drugs
Trial Snapshot
- Phase
- Phase 2
- Enrollment
- 80
- Locations
- 1
- Primary Endpoint
- action in inflammmatory biologic makers
Study Overview
Brief Summary
The purpose of this study is to determine whether atorvastatin can improve the inflammatory answer in the septic patients
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Eligibility Criteria
- Ages
- 15 Years to — (Child, Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •clinical diagnosis of several sepsis or shock septic
- •no more than twenty four hours than diagnosis
Exclusion Criteria
- •use of statins in the last thirty days
- •unequivocal indication for statin treatment
- •active treatment with imunosuppressors drugs
- •High risk of rhabdomyolysis: multiple trauma, crush injuries, baseline creatinine kinase > three times upper limit of normal
- •diagnosis of AIDS
- •unable to receive enteral medications
- •pregnancy
- •expected survival of less than 48 hours
Arms & Interventions
amido pill
Placebo Comparator
Intervention: amido pill (Drug)
atorvastatina
Experimental
atrovastatina 80 mg/d by mouth for 10 days
Intervention: atorvastatina (Drug)
Outcomes
Primary Outcomes
action in inflammmatory biologic makers
Time Frame: 24h; 72h; 10 days
valuation of flow-mediated vasodilation of the brachial artery
Time Frame: 24h; 72; 10 days
Secondary Outcomes
- mortality(at end)
- time of permanence in intensive care unity(at end)
- time of permanence in mechanical ventilation(at end)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Terminated
Not Applicable
Effect of Acute Statin Treatment in Patients Undergoing Percutaneous Coronary InterventionCoronary Artery DiseaseNCT00588471Mayo Clinic57
Completed
Not Applicable
Effect of Rosuvastatin Response in Healthy Subjects: Potential Mechanisms of Anti-inflammatory EffectsHealthyNCT00874757University of Nebraska20
Completed
Phase 4
Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early AtherosclerosisInflammationNCT00361283University of Florida108
Unknown
Phase 2
Statin Treatment for UnruptureD Intracranial anEurysms StudyInflammation VascularIntracranial AneurysmNCT04149483Beijing Neurosurgical Institute60
Unknown
Not Applicable
Atorvastatin in the TREATment of Intracranial Unruptured VertebroBasilar Dissecting AneurysmsDissecting Aneurysm of Cerebral ArteryIntramural HematomasInflammation VascularNCT04943783Beijing Neurosurgical Institute40
